Drug Report History #3045

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.

Field Version v12-EN Version v4-EN
Language English English
Date Updated 2017-04-21 (Updated) 2017-04-11
Drug Identification Number 01997602 01997602
Brand name DANTRIUM CAPSULES DANTRIUM CAPSULES
Common or Proper name Dantrolene Sodium Capsules Dantrolene Sodium Capsules
Company Name PAR PHARMACEUTICAL COMPANIES PAR PHARMACEUTICAL COMPANIES
Ingredients DANTROLENE SODIUM DANTROLENE SODIUM
Strength(s) 25MG 25MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 100 capsules/bottle 100 capsules/bottle
ATC code M03CA M03CA
ATC description MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date (Updated) 2017-01-10
Actual start date 2017-01-10 2017-01-10
Estimated end date (Updated) 2017-03-31
Actual end date 2017-04-21 (Updated) 2017-04-11
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments Shortage has been resolved (Updated) Product on allocation. Please contact Methapharm Customer Service 1-800-287-7686, option 3, [email protected]
Health Canada comments